CoreCivic Q2 net income falls to $37.1 million; revenue totals $684.9 million
CXW•Second-quarter results and capital actions
- CoreCivic posted 2Q 2026 net income of $37.1 million on revenue of $684.9 million.
- Diluted EPS was $0.37; adjusted diluted EPS (non-GAAP) was $0.38.
- Adjusted EBITDA (non-GAAP) totaled $109.4 million; trailing 12-month debt leverage was 2.9x.
- The company acquired Clinical Solutions Pharmacy on April 1, 2026 for about $148 million and expects $215 million to $230 million of 2026 revenue contribution.
- CoreCivic entered a $500 million accelerated share repurchase on Aug. 7, 2026 and took delivery of about 12,400,000 shares on Aug. 10.
